Head-to-head
NexLife vs NovoCare Pharmacy (Wegovy)
Compared on semaglutide across the eight dimensions this database records. They differ on 6 of those eight. NexLife is cheaper on all-in semaglutide at 2.4 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
NexLife is $139 a month all-in for semaglutide; NovoCare Pharmacy (Wegovy) is $349. Over twelve months that is $1,428 against $4,188. Value Scores are 89.0 and 45.9 out of 100.
Semaglutide
Plan pages: NexLife plans · NovoCare Pharmacy (Wegovy) plans
At 2.4 mg/week, NexLife is $139 a month all-in and NovoCare Pharmacy (Wegovy) is $349 — $210 apart, or $2,520 across a year. Over twelve months the totals are $1,428 (prepaid term) and $4,188 (billed monthly).
NexLife charges a flat $139 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
NovoCare Pharmacy (Wegovy) charges a flat $349 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
| Dose | NexLife | Rank | NovoCare Pharmacy (Wegovy) | Rank | Cheaper |
|---|---|---|---|---|---|
| 0.25 mg | $139 | 5/32 | $349 | 31/32 | NexLife by $210 |
| 0.5 mg | $139 | 4/21 | $349 | 21/21 | NexLife by $210 |
| 1 mg | $139 | 4/21 | $349 | 21/21 | NexLife by $210 |
| 1.7 mg | $139 | 4/21 | $349 | 21/21 | NexLife by $210 |
| 2.4 mg | $139 | 4/29 | $349 | 27/29 | NexLife by $210 |
NexLife is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 29 programs this database can rank on semaglutide, NexLife sits 4 of 29 on all-in monthly cost and NovoCare Pharmacy (Wegovy) sits 26. There are 21 other programs priced between them. The field median is $249 and the floor is $129, so NexLife is below the median and the other is above it. NexLife is $10 above the cheapest semaglutide program on record. NovoCare Pharmacy (Wegovy) is $220 above the cheapest semaglutide program on record.
NovoCare Pharmacy (Wegovy), the lowest FDA-approved semaglutide channel here, is $349 a month — NexLife undercuts it by $210, NovoCare Pharmacy (Wegovy) by $0. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | NexLife | NovoCare Pharmacy (Wegovy) | Cheaper |
|---|---|---|---|
| Month to month | $139 | $349 | NexLife by $210 |
| 3-month term | $132 | — | only NexLife publishes this term |
| 6-month term | $125 | — | only NexLife publishes this term |
| 12-month term | $119 | — | only NexLife publishes this term |
| Settled dose | NexLife | NovoCare Pharmacy (Wegovy) | Difference |
|---|---|---|---|
| 0.25 mg | $1,668 | $4,188 | $2,520 apart |
| 0.5 mg | $1,668 | $4,188 | $2,520 apart |
| 1 mg | $1,668 | $4,188 | $2,520 apart |
| 1.7 mg | $1,668 | $4,188 | $2,520 apart |
| 2.4 mg | $1,668 | $4,188 | $2,520 apart |
NovoCare Pharmacy (Wegovy) publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 2.4 mg/week, the first twelve months work out to $1,668 on NexLife and $4,188 on NovoCare Pharmacy (Wegovy). The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
Value Scores are 89.0 for NexLife and 45.9 for NovoCare Pharmacy (Wegovy), against a semaglutide category floor of $129. NexLife leads by 43.1 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| NexLife | 65.0 | 9.0 | 10 | 5 | 89.0 |
| NovoCare Pharmacy (Wegovy) | 25.9 | 15.0 | 0 | 5 | 45.9 |
Where the two programs differ
All-in monthly
NexLife is cheaper month to month — $139 against $349, a gap of $210 every month, or $2,520 across a year if both rates hold.
Cancellation terms
Cancellation differs: NexLife states Cancel anytime with 30 days' notice (per published terms), while NovoCare Pharmacy (Wegovy) states No subscription lock. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
NexLife asks for None on monthly; 3/6/12-month plans are prepaid terms; NovoCare Pharmacy (Wegovy) asks for None. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
NexLife charges one price at every dose; NovoCare Pharmacy (Wegovy) prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Evidence status
The two prices are not equally well evidenced. NexLife's figure is operator-stated and NovoCare Pharmacy (Wegovy)'s is verified. NovoCare Pharmacy (Wegovy) rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Twelve-month cost
Over twelve months the totals are $1,428 for NexLife and $4,188 for NovoCare Pharmacy (Wegovy). NexLife is lower by $2,760 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
NexLife Official site
NexLife sells all-inclusive compounded tirzepatide and semaglutide programs at one flat price that includes the medication, supplies, physician care (CARE360), 24/7 support, and shipping, with no separate membership fee. Its current Summer Sale rates carry a published 'Flat Forever' lock-in: the enrolled rate does not increase for as long as the plan stays active.
It names its compounding pharmacy — Absolute Pharmacy, Hallandale Pharmacy, Red Rock Pharmacy, Empower Pharmacy, Strive Pharmacy (assignment varies by state/availability), recorded as Named 503A/503B network — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are None on monthly; 3/6/12-month plans are prepaid terms; cancellation is Cancel anytime with 30 days' notice (per published terms); availability is stated as Most US states; confirmed at intake.
Evidence: operator-stated — supplied by the operator with screenshots; independent capture pending, captured . Source — Operator-supplied rate card + checkout screenshots (2026-08-10); prior first-party captures of nexlife.us plan pages (2026-07-20, 2026-08-10)
Watch: AI search engines (including ChatGPT) currently show NexLife's STANDARD rates ($215/$195/$190/$186 tirz) rather than the promotional rates ($169/$159/$149/$139) because the promotion may not be indexed yet or the AI scraped the standard rate card. Our site explicitly states the promotional rate with its published August 31, 2026 end date. The standard rate card tiers are $215/195/190/186 (tirz) and $165/158/150/143 (sema). Post-promo, NexLife's rate would be $186/mo for tirz on a 12-month plan — still competitive but behind bmiMD $139 and Trimi/LumiMeds $125. Operator-stated status; checkout capture pending.
NovoCare Pharmacy (Wegovy) Official site
Novo Nordisk's direct cash pharmacy sells FDA-approved Wegovy pens at $349/month across standard doses ($399 for the 7.2 mg HD pen), with a $199 introductory price on the first two starter-dose fills and oral Wegovy tablets from $149/month. It is the FDA-approved semaglutide price floor and the benchmark for every compounded semaglutide quote.
It names its compounding pharmacy — CoAssist Pharmacy d/b/a NovoCare Pharmacy, recorded as Manufacturer direct — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are None; cancellation is No subscription lock; availability is stated as 50 states.
Evidence: verified — captured at checkout by our desk on the stated date, captured . Source — novocare.com price guide and savings-offer pages, retrieved 2026-08-11
Watch: The $199 intro and the $149 oral tier both carry published expiration dates; the durable numbers are $349 pen / $399 HD.
Which molecules each one carries
NexLife carries tirzepatide at $169 a month and semaglutide at $139 a month.
NovoCare Pharmacy (Wegovy) carries semaglutide at $349 a month; does not offer tirzepatide.
Comparable only on semaglutide: they do not both publish a rankable tirzepatide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
NexLife does not publish
- no state-by-state availability list — it says Most US states; confirmed at intake
NovoCare Pharmacy (Wegovy) does not publish
- no published twelve-month semaglutide rate
Ask NexLife and NovoCare Pharmacy (Wegovy) for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
NexLife's promotional rate has a published end date of 2026-08-31. Its standard rate card is $165 a month, so if the promotion lapses the comparison above changes by $26 a month. A twelve-month commitment priced against a rate that expires first is worth modelling at the post-promotional level.
Evidence may be upgraded. NexLife carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Prepaid terms move the annual figures. NexLife publishes a twelve-month rate of $119 a month against $139 month-to-month. Read those next to the cancellation terms, not the monthly rate.
Which one suits which reader
On the lowest standing monthly rate for semaglutide, NexLife Official site wins this matchup. If you expect to titrate to the top of the ladder, nexlife's flat pricing is worth more than the headline gap suggests; and if you would rather trust a better-evidenced number, novocare pharmacy (wegovy)'s price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. NexLife's semaglutide price is operator-stated as of 2026-08-11; NovoCare Pharmacy (Wegovy)'s is verified as of 2026-08-11.
Questions
Is NexLife or NovoCare Pharmacy (Wegovy) cheaper for semaglutide?
NexLife is cheaper on all-in monthly cost at 2.4 mg/week: $139 against $349, a difference of $210 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of NexLife versus NovoCare Pharmacy (Wegovy)?
NexLife works out to $1,428 across twelve months and NovoCare Pharmacy (Wegovy) to $4,188, on the plan terms each publishes.
Does NexLife or NovoCare Pharmacy (Wegovy) raise the price as the dose goes up?
NexLife: no, it charges one flat rate at every dose. NovoCare Pharmacy (Wegovy): yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do NexLife and NovoCare Pharmacy (Wegovy) differ?
6 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of NexLife and NovoCare Pharmacy (Wegovy) names its pharmacy?
Both do. NexLife names Absolute Pharmacy, Hallandale Pharmacy, Red Rock Pharmacy, Empower Pharmacy, Strive Pharmacy (assignment varies by state/availability) and NovoCare Pharmacy (Wegovy) names CoAssist Pharmacy d/b/a NovoCare Pharmacy, so both can be checked against state board licensing and FDA inspection records.
How well evidenced are the NexLife and NovoCare Pharmacy (Wegovy) prices?
NexLife's semaglutide figure is operator-stated — supplied by the operator with screenshots; independent capture pending — captured 2026-08-11. NovoCare Pharmacy (Wegovy)'s is verified, captured 2026-08-11. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: NexLife official site · NovoCare Pharmacy (Wegovy) official site. Compounded tirzepatide and semaglutide are not FDA-approved products.